F8 and androgen insensitivity syndrome: Less is known about the levels of FVIII and VWF during the course of thrombolysis in AIS patients—even though it has been speculated based on animal studies that the degradation of FVIII during thrombolysis treatment could be a potential causative factor for bleeding complications occurring in treated patients (16).